Division of Hematology and Oncology, Department of Internal Medicine, Taichung Armed Forces General Hospital, Taichung 411, Taiwan.
Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan.
Medicina (Kaunas). 2022 Feb 4;58(2):236. doi: 10.3390/medicina58020236.
Immunoglobulin G4-related disease (IgG4-RD) is a systemic fibro-inflammatory and idiopathic autoimmune disorder. IgG4-RD can be characterized by the presence of pseudotumors. Inflammatory pseudotumors may involve any part of a human organ. There are few reports of sinus lesions in IgG4-RD. An 82-year-old man has a history of chronic sinusitis for the last several years and no remarkable family history. Two years before disease presentation, the patient experienced intermittent nasal bleeding, stuffy nose, dizziness, and fatigue. Blood test revealed positive (160X) antinuclear antibody with a mixed speckled and nucleolar pattern, IgG level of 1370 mg/dL, and IgG4 level of 99.7 mg/dL. Computed tomography (CT) of the sinus revealed several calcifications in the sphenoid sinus. Surgical findings revealed tumor-like materials. Pathological examination of the soft tissues revealed acute and chronic granulomatous inflammation. Immunohistochemical analysis demonstrated high levels of positive-affinity markers of IgG, IgG4, and CD138 and a IgG4/IgG ratio > 40%. IgG4-RD with pseudotumor was diagnosed. The initial treatment was intravenous methylprednisolone 120 mg daily for three days and oral prednisolone 10 mg twice a day and azathioprine 50 mg daily. The efficacy of the treatment was insufficient, and nasal bleeding did not decrease. Subsequently administered intravenous rituximab 1000 mg monthly for 2 months. Following this treatment, nasal bleeding stopped. CT revealed reduction in nasal mucosal swelling compared with that in a previous scan. This report highlights that in cases with an inflammatory mass mimicking malignancy, IgG4RD should always be considered, and rituximab treatment is recommended upon failure of steroid and azathioprine therapy.
免疫球蛋白 G4 相关疾病(IgG4-RD)是一种系统性纤维炎症性和特发性自身免疫性疾病。IgG4-RD 的特征是存在假肿瘤。炎症性假肿瘤可累及人体任何器官的部位。IgG4-RD 中鼻窦病变的报道较少。一名 82 岁男性,患有慢性鼻窦炎病史数年,无明显家族史。在疾病发作前两年,患者出现间歇性鼻出血、鼻塞、头晕和乏力。血液检查显示抗核抗体阳性(160X),呈混合斑点和核仁模式,IgG 水平为 1370mg/dL,IgG4 水平为 99.7mg/dL。鼻窦 CT 显示蝶窦内有几个钙化灶。手术发现肿瘤样物质。软组织病理检查显示急性和慢性肉芽肿性炎症。免疫组化分析显示 IgG、IgG4 和 CD138 的高亲和力标志物呈阳性,且 IgG4/IgG 比值>40%。诊断为 IgG4-RD 伴假肿瘤。初始治疗为静脉注射甲基强的松龙 120mg/d,连用 3 天,口服泼尼松 10mg 每天两次和硫唑嘌呤 50mg/d。治疗效果不佳,鼻出血未减少。随后给予静脉注射利妥昔单抗 1000mg 每月一次,连用 2 个月。治疗后,鼻出血停止。CT 显示与前一次扫描相比,鼻黏膜肿胀减轻。本报告强调,在炎症性肿块类似于恶性肿瘤的情况下,始终应考虑 IgG4-RD,并且在类固醇和硫唑嘌呤治疗失败后推荐使用利妥昔单抗治疗。